Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

1.

Identification and evaluation of network modules for the prognosis of basal-like breast cancer.

Hallett RM, Cockburn JG, Li B, Dvorkin-Gheva A, Hassell JA, Bane A.

Oncotarget. 2015 Jul 10;6(19):17713-24.

2.

Treatment-induced cell cycle kinetics dictate tumor response to chemotherapy.

Hallett RM, Huang C, Motazedian A, Auf der Mauer S, Pond GR, Hassell JA, Nordon RE, Draper JS.

Oncotarget. 2015 Mar 30;6(9):7040-52.

3.

Immune cell transcript modules reveal leukocyte heterogeneity in synovial biopsies of seronegative spondylarthropathy patients.

Hallett RM, Chew T.

BMC Musculoskelet Disord. 2014 Dec 19;15:446. doi: 10.1186/1471-2474-15-446.

4.

Estrogen independent gene expression defines clinically relevant subgroups of estrogen receptor positive breast cancer.

Hallett RM, Hassell JA.

BMC Cancer. 2014 Nov 24;14:871. doi: 10.1186/1471-2407-14-871.

5.

A program to identify prognostic and predictive gene signatures.

Chorlton SD, Hallett RM, Hassell JA.

BMC Res Notes. 2014 Aug 18;7:546. doi: 10.1186/1756-0500-7-546.

6.

Mammary glands exhibit molecular laterality and undergo left-right asymmetric ductal epithelial growth in MMTV-cNeu mice.

Robichaux JP, Hallett RM, Fuseler JW, Hassell JA, Ramsdell AF.

Oncogene. 2015 Apr 9;34(15):2003-10. doi: 10.1038/onc.2014.149. Epub 2014 Jun 9.

PMID:
24909172
7.

FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells.

Manoranjan B, Wang X, Hallett RM, Venugopal C, Mack SC, McFarlane N, Nolte SM, Scheinemann K, Gunnarsson T, Hassell JA, Taylor MD, Lee C, Triscott J, Foster CM, Dunham C, Hawkins C, Dunn SE, Singh SK.

Stem Cells. 2013 Jul;31(7):1266-77. doi: 10.1002/stem.1401.

8.

Single unpurified breast tumor-initiating cells from multiple mouse models efficiently elicit tumors in immune-competent hosts.

Kurpios NA, Girgis-Gabardo A, Hallett RM, Rogers S, Gludish DW, Kockeritz L, Woodgett J, Cardiff R, Hassell JA.

PLoS One. 2013;8(3):e58151. doi: 10.1371/journal.pone.0058151. Epub 2013 Mar 26.

9.

A cancer stem cell model for studying brain metastases from primary lung cancer.

Nolte SM, Venugopal C, McFarlane N, Morozova O, Hallett RM, O'Farrell E, Manoranjan B, Murty NK, Klurfan P, Kachur E, Provias JP, Farrokhyar F, Hassell JA, Marra M, Singh SK.

J Natl Cancer Inst. 2013 Apr 17;105(8):551-62. doi: 10.1093/jnci/djt022. Epub 2013 Feb 15.

10.

A target based approach identifies genomic predictors of breast cancer patient response to chemotherapy.

Hallett RM, Pond G, Hassell JA.

BMC Med Genomics. 2012 May 11;5:16. doi: 10.1186/1755-8794-5-16.

11.

Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.

Hallett RM, Kondratyev MK, Giacomelli AO, Nixon AM, Girgis-Gabardo A, Ilieva D, Hassell JA.

PLoS One. 2012;7(3):e33976. doi: 10.1371/journal.pone.0033976. Epub 2012 Mar 28.

12.

A gene signature for predicting outcome in patients with basal-like breast cancer.

Hallett RM, Dvorkin-Gheva A, Bane A, Hassell JA.

Sci Rep. 2012;2:227. doi: 10.1038/srep00227. Epub 2012 Jan 17. No abstract available.

13.

Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer.

Kondratyev M, Kreso A, Hallett RM, Girgis-Gabardo A, Barcelon ME, Ilieva D, Ware C, Majumder PK, Hassell JA.

Oncogene. 2012 Jan 5;31(1):93-103. doi: 10.1038/onc.2011.212. Epub 2011 Jun 13.

PMID:
21666715
14.

E2F1 and KIAA0191 expression predicts breast cancer patient survival.

Hallett RM, Hassell JA.

BMC Res Notes. 2011 Mar 31;4:95. doi: 10.1186/1756-0500-4-95.

15.

An algorithm to discover gene signatures with predictive potential.

Hallett RM, Dvorkin A, Gabardo CM, Hassell JA.

J Exp Clin Cancer Res. 2010 Sep 2;29:120. doi: 10.1186/1756-9966-29-120.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk